V

Vaccinex

D
VCNX
USD
0.2
(6.3091%)
Market Closed
6,433.00
حجم التداول
-0.4
الربح لكل سهم
-
العائد الربحي
-0.851010
P/E
8,761,083.36
حجم السوق
اليوم
0.5670%
1 اسبوع
22.101%
1 شهر
39.834%
6 اشهر
-45.292%
12 اشهر
-74.255%
بداية السنة
-62.193%
كل الوقت
0%

Title:
Vaccinex

Sector:
Healthcare
Industry:
Biotechnology
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb.
هل تحتاج مساعدة او لديك استفسار؟